Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III randomized double-blind placebo-controlled study of epoetin beta for chemotherapy-induced anemia in cancer patients
jRCT2080220560Phase 3
- Sponsor
- Chugai Pharmaceutical Co., Ltd.
- Start
- May 2008
- Modality
- Erythropoietins → Hormones & Growth Factors → Recombinant Proteins and Enzymes, Interleukins → Cytokines & Interferons → Recombinant Proteins and Enzymes, Colony Stimulating Factors → Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in chemotherapy-induced anaemia (CIA), bronchial carcinoma and gynecological cancer comparing Epoetin beta with Placebo (2 arms).
02
Drugs
epoetin beta
03
Conditions
chemotherapy-induced anaemia (CIA)bronchial carcinomagynecological cancer
Beyond the preview
Go deeper on jRCT2080220560.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220560.